It’s controversial. But it’s also one of the most profitable opportunities you can’t ignore.
It’s already doubled – even tripled returns in months.
- GW Pharmaceuticals (GWPH) soared from a low of $39 to $140
- Kush Bottles (KSHB) jumped from $1 to $5
- Canopy Growth (TWMJF) rocketed from $3 to $14
Colorado just passed the $1 billion market for annual marijuana sales.
And it could be about to happen all over again for smart investors.
Whether you like it or not, the marijuana story isn’t going away.
So why not profit from it? As of now, 28 states have legalized its medicinal use. Another eight states have approved it for recreational use for those 21 and older.
All as approval for its legalization soars to an all-time high of 60%.
Favorability for medicinal usage is even higher, with six out of seven Americans for it.
It’s tough to argue against investing in related stocks when you have an industry with a 24% compound growth rate over the next 10 years. By 2026, this could easily be a $50 billion industry… with an opportunity to buy in on the ground floor right now.
Look at Kush Bottles (KSHB) for example.
On November 3, it posted record revenue of $8.2 million, a 105% jump year over year. Operating revenue soared 124% year over year. Capital jumped 877% to $2.02 million. Operating expenses was 32%, which represents a year over year decreased of 12%.
Yet the stock trades at $2.85 a share. That’s cheap considering the future pace of growth.
But that growth isn’t just limited to the U.S.
Up north, Canadian Prime Minister Justin Trudeau commissioned a report from the Task Force on Cannabis Legalization and Regulation, which is recommending that the government regulate the production of marijuana while the provinces control the distribution and retail sales operations.
At the moment, only medicinal marijuana is legal in the country.
But with overwhelming government and voter support, that could change shortly, creating a windfall profit opportunity. Right now, 62% of Canadians support the move with legislation likely by the spring of 2017.
If that’s the case, Canada could see $5.3 billion in annual revenue from marijuana sales alone. That could balloon to $8.7 billion shortly after, as marijuana retail sales in Canada alone.
The industry has gotten so big that growers may have to produce up to 600,000 kilograms of marijuana every year – just to keep up with demand.
And again, smart investors are taking notice.
One of the companies to watch in Canada is Canopy Growth (TWMJF). The company just posted revenue of $8.5 million (a 22% increase year over year). Net income of $5.4 million was a respectable jump from the $3.9 million posted year over year.
Again, that’s solid growth that can’t be ignored.
With a coming marijuana sales boom, these are stocks that can’t be ignored.
Controversial or not, it’s a topic that could help you retire earlier than planned.
